Mutual Fund Details
NAV
₹11.8240
as on 20 Jan 2020, 09:45 PM
₹0.0720(0.61%)
Last Change
Schemes Managed By
Start SIP in this Mutual Fund
Min SIP Amount
₹500
Suggested Date
21st of Every Month
Investment Performance
would have given a return of
₹103,499
₹106,749
₹114,726
₹116,785
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹16,785
Profit (absolute return)
16.79%
in the last
1m
3m
1y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
14.83%
In the last 6 months
18.04%
In the last 1 year
16.79%
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
moderately low
moderate
moderately high
high
Investors understand that their principal will be at high risk
Scheme Information
DSP Healthcare Fund Direct - Growth
as of 20 Jan 2020, 09:45 PM
₹243.42 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 12 months.
0.22%
Expense Ratio
Plan
Growth
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 12 months.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Dec 2019
Healthcare
91.94%
₹223.80 Cr
Financial
5.43%
₹13.22 Cr
Cash Holding
2.63%
₹6.40 Cr
Companies Holding in this Mutual Fund
as on 31 Dec 2019
Dr. Reddy's Laboratories Ltd.
10.41%
₹25.34 Cr
Ipca Laboratories Ltd.
9.63%
₹23.44 Cr
JB Chemicals & Pharmaceuticals Ltd.
6.94%
₹16.89 Cr
Divi's Laboratories Ltd.
6.80%
₹16.55 Cr
Sun Pharmaceutical Inds. Ltd.
6.12%
₹14.90 Cr
Apollo Hospitals Enterprise Ltd.
5.85%
₹14.24 Cr
Indoco Remedies Ltd.
5.37%
₹13.07 Cr
Jubilant Life Sciences Ltd.
4.15%
₹10.10 Cr
Max India Ltd.
3.86%
₹9.40 Cr
Syngene International Ltd.
3.77%
₹9.18 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Dec 2019
Dr. Reddy's Laboratories Ltd.
10.41%
₹25.34 Cr
Ipca Laboratories Ltd.
9.63%
₹23.44 Cr
JB Chemicals & Pharmaceuticals Ltd.
6.94%
₹16.89 Cr
Divi's Laboratories Ltd.
6.80%
₹16.55 Cr
Sun Pharmaceutical Inds. Ltd.
6.12%
₹14.90 Cr
Apollo Hospitals Enterprise Ltd.
5.85%
₹14.24 Cr
Indoco Remedies Ltd.
5.37%
₹13.07 Cr
Jubilant Life Sciences Ltd.
4.15%
₹10.10 Cr
Max India Ltd.
3.86%
₹9.40 Cr
Syngene International Ltd.
3.77%
₹9.18 Cr
View All
View All
This fund's returns:
16.79%Return Duration
1 Year
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹1000
Category Returns
3.03%
16.78%
1Y Returns
13.09
Tata India Pharma & HealthCare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
3.03%
16.78%
1Y Returns
11.37
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
3.03%
16.78%
1Y Returns
11.04
UTI Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
3.03%
16.78%
1Y Returns
7.13
Nippon India Pharma Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
3.03%
16.78%
1Y Returns
5.15
About DSP Healthcare Fund Direct - Growth
DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on 30 Nov 2018 and is currently managed by its fund managers Vinit Sambre and Aditya Khemka. It has an AUM of ₹243.42 Crores and the latest NAV decalared is ₹11.824 as on 20 Jan 2020 at 9:45 pm.
DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is 16.79%, is 17.61% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
| AUM: | ₹243.42 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | 30 Nov 2018 |
| Fund Type: | Open-End |
Scheme Objective
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
AMC Information
DSP Mutual Fund
View AMC Details
₹77,586.41 Cr
AUM
98
Schemes
Address
NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road JunctionWestern Express Highway,Andheri East400069
Phone Number
Phone : 022-66178000
Fax : 022-56578181
Email / Website
